Haidan Guo

Author PubWeight™ 9.03^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	The impact of mouse passaging of Mycobacterium tuberculosis strains prior to virulence testing in the mouse and guinea pig aerosol models.	PLoS One	2010	1.03
2	Successful shortening of tuberculosis treatment using adjuvant host-directed therapy with FDA-approved phosphodiesterase inhibitors in the mouse model.	PLoS One	2012	0.99
3	Risk of tuberculosis reactivation with tofacitinib (CP-690550).	J Infect Dis	2012	0.99
4	Pharmacokinetic and in vivo efficacy studies of the mycobactin biosynthesis inhibitor salicyl-AMS in mice.	Antimicrob Agents Chemother	2013	0.97
5	Rv2190c, an NlpC/P60 family protein, is required for full virulence of Mycobacterium tuberculosis.	PLoS One	2012	0.96
6	Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.	J Med Chem	2013	0.91
7	Alterations in phospholipid catabolism in Mycobacterium tuberculosis lysX mutant.	Front Microbiol	2011	0.86
8	Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis.	Nat Commun	2012	0.84
9	Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis.	J Antimicrob Chemother	2011	0.83
10	Detection of inhibitors of phenotypically drug-tolerant Mycobacterium tuberculosis using an in vitro bactericidal screen.	J Microbiol	2013	0.81